Lunai Bioworks (LNAI) EPS (Diluted) (2014 - 2026)
Lunai Bioworks (LNAI) EPS (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.15 |
| 10 | Lunai Bioworks | 7.12 Mn | 3.97 Mn | 20,942.00 | -0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.51 |
| Dec 31, 2025 | -0.66 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -61.26 |
| Mar 31, 2025 | -2.12 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -27.32 |
| Jun 30, 2024 | -13.60 |
| Mar 31, 2024 | -38.50 |
| Dec 31, 2023 | -5.52 |
| Sep 30, 2023 | -11.38 |
| Jun 30, 2023 | -32.98 |
| Mar 31, 2023 | -6.19 |
| Dec 31, 2022 | -6.42 |
| Sep 30, 2022 | -11.18 |
| Jun 30, 2022 | -137.43 |
| Mar 31, 2022 | -52.04 |
| Dec 31, 2021 | -55.24 |
| Sep 30, 2021 | -87.37 |
| Jun 30, 2021 | -145.70 |